The present study supports a model in which Pten loss-induced senescence is hindered in prostate tumor cells by non cell-autonomous mechanisms. Indeed, paracrine signaling by tumor-infiltrating CD11b+Gr-1+ myeloid cells triggers senescence evasion in prostate lesions of Pten-null mice, eventually promoting tumor progression
Prostate cancer, is one of the most common cancers in men worldwide (after lung cancer), and involv...
Enhancement of cellular senescence in tumours triggers a stable cell growth arrest and activation of...
AbstractThe murine Pten prostate cancer model described in this study recapitulates the disease prog...
The present study supports a model in which Pten loss-induced senescence is hindered in prostate tum...
Aberrant activation of oncogenes or loss of tumour suppressor genes opposes malignant transformation...
Aberrant activation of oncogenes or loss of tumour suppressor genes opposes malignant transformation...
International audienceWe report that Pten (phosphatase and tensin homologue) ablation in prostatic e...
Irreversible cell growth arrest, a process termed cellular senescence, is emerging as an intrinsic t...
SummaryProsenescence therapy has recently emerged as a novel therapeutic approach for treating cance...
Chronic inflammation is known to be associated with prostate cancer development, but how epithelium-...
Chronic inflammation is known to be associated with prostate cancer development, but how epithelium-...
Cellular senescence has been theorized to oppose neoplastic transformation triggered by activation o...
Aberrant activation of oncogenes or down regulation of tumour suppressor genes trigger a premature s...
: Tumor cells promote the recruitment of immunosuppressive neutrophils, a subset of myeloid cells dr...
Despite recent progresses, prostate cancer (PC) is still the second most diagnosed cancer and the si...
Prostate cancer, is one of the most common cancers in men worldwide (after lung cancer), and involv...
Enhancement of cellular senescence in tumours triggers a stable cell growth arrest and activation of...
AbstractThe murine Pten prostate cancer model described in this study recapitulates the disease prog...
The present study supports a model in which Pten loss-induced senescence is hindered in prostate tum...
Aberrant activation of oncogenes or loss of tumour suppressor genes opposes malignant transformation...
Aberrant activation of oncogenes or loss of tumour suppressor genes opposes malignant transformation...
International audienceWe report that Pten (phosphatase and tensin homologue) ablation in prostatic e...
Irreversible cell growth arrest, a process termed cellular senescence, is emerging as an intrinsic t...
SummaryProsenescence therapy has recently emerged as a novel therapeutic approach for treating cance...
Chronic inflammation is known to be associated with prostate cancer development, but how epithelium-...
Chronic inflammation is known to be associated with prostate cancer development, but how epithelium-...
Cellular senescence has been theorized to oppose neoplastic transformation triggered by activation o...
Aberrant activation of oncogenes or down regulation of tumour suppressor genes trigger a premature s...
: Tumor cells promote the recruitment of immunosuppressive neutrophils, a subset of myeloid cells dr...
Despite recent progresses, prostate cancer (PC) is still the second most diagnosed cancer and the si...
Prostate cancer, is one of the most common cancers in men worldwide (after lung cancer), and involv...
Enhancement of cellular senescence in tumours triggers a stable cell growth arrest and activation of...
AbstractThe murine Pten prostate cancer model described in this study recapitulates the disease prog...